Replicated evidence for an accelerated rate of whole-body aging in schizophrenia.
Abstract
People with schizophrenia develop more chronic diseases at a younger age and die younger than people in the general population. It has been hypothesized that this excess morbidity and mortality could be partially due to accelerated aging in schizophrenia. If true, this would motivate the development of 'gero-protective' interventions to reduce chronic disease burden in schizophrenia. However, it has been difficult to test this hypothesis, in part, due to the limited ability to measure aging in samples of people with schizophrenia.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper claims that schizophrenia is associated with an accelerated rate of whole-body aging. This is relevant as it explores the potential underlying mechanisms of aging in a specific population, which could inform interventions aimed at mitigating age-related diseases.
Author of this paper? Send a correction.